After thoroughly reviewing the content of the study, here is an organized analysis of potential research impacts that align with common dimensions of research impact:

1. Domains of Research Impact:
Academic Domain: The study advances knowledge by developing a database of excipient toxicity, influencing fields like toxicology, pediatric pharmacology, and regulatory science. It creates a foundation for further research in pediatric drug safety.
Health Domain: It directly impacts the healthcare sector by addressing pediatric safety in pharmaceuticals, contributing to safer medication formulations for children.
Technological Domain: The creation of the STEP database integrates technology into drug safety, improving data management and reducing redundancy in toxicity studies.
Policy Domain: The study could guide pharmaceutical regulatory bodies in creating policies for the use of excipients in pediatric drugs.
Source: Multiple references in the study discuss these domains, including the study’s conclusion about enhancing pediatric medication safety and regulatory support​(Knowledge - Potential R…)​(impact pathway)​(Research Impact Knowled…).

2. Duration of Research Impact:
Short-term Impact: Immediate use of the database for clinical trials and regulatory assessments improves drug safety and accelerates decision-making in pharmaceutical research.
Long-term Impact: As the database expands and integrates more excipients, it could lead to broad, enduring changes in global pediatric medication safety over time​(Knowledge - Potential R…)​(Research impact toolkit).
3. Stakeholders of Research Impact:
Researchers: The database serves as a resource for researchers in toxicology, pharmacology, and pediatrics, aiding future research and validation.
Healthcare Providers: It directly benefits healthcare providers by ensuring safer drug formulations, improving patient care in pediatric medicine.
Regulators: Regulatory bodies are key stakeholders, benefiting from a centralized data source for decision-making on drug approvals.
Pharmaceutical Industry: The database helps pharmaceutical companies avoid redundant research, lowering costs and improving drug development efficiency​(Common Research Impact …)​(impact pathway).
4. Depth and Breadth of Impact:
Deep Impact: The study has a deep impact on pediatric drug safety by fundamentally changing the way excipients are evaluated and used in medications.
Broad Impact: It has broad implications across healthcare, policy, and pharmaceutical industries by offering a scalable solution to improve medication safety globally​(impact pathway)​(Common Research Impact …).
5. Scalability and Transferability:
Scalability: The STEP database can scale up to include more excipients and be adopted internationally, improving pediatric drug safety across different regions.
Transferability: The database structure is adaptable and could be transferred to other domains within the pharmaceutical industry, such as adult medications or medical device safety​(Common Research Impact …)​(impact pathway)​(Research impact toolkit).
6. Innovation and Disruption Potential:
Innovation: The introduction of a centralized excipient toxicity database is innovative, offering a novel way to streamline access to critical data.
Disruption: The study disrupts traditional methods of drug safety assessment by reducing reliance on repetitive toxicology studies, promoting more efficient and evidence-based decision-making​(Common Research Impact …)​(Research impact toolkit).
7. Sustainability and Ethical Considerations:
Sustainability: By reducing the need for repeated toxicology studies, the research promotes sustainability in pharmaceutical research, conserving resources and reducing animal testing.
Ethical Considerations: The study addresses ethical concerns around pediatric drug safety and aims to protect vulnerable populations through better regulatory frameworks​(impact pathway)​(Research Impact Knowled…).
8. Implementation and Usability:
Usability: The database is user-friendly and designed for immediate implementation by pharmaceutical companies, regulators, and healthcare providers, allowing real-time access to excipient safety data​(Common Research Impact …)​(Research impact toolkit).
9. Cross-disciplinary and Global Relevance:
Cross-disciplinary: The research integrates toxicology, pharmacology, and information technology, benefiting multiple scientific disciplines.
Global Relevance: The STEP database can be applied globally, providing a standardized tool for pediatric medication safety across different regulatory environments​(Common Research Impact …)​(impact pathway).
10. Resilience and Adaptability:
Resilience: The database is designed to evolve with the inclusion of new excipients, ensuring it remains relevant to future pharmaceutical challenges.
Adaptability: It can be adapted to address emerging drug safety concerns, making it a flexible tool for regulatory bodies and the pharmaceutical industry​(Common Research Impact …)​(Research Impact Knowled…).
Additional Impacts:
Economic Impact: The database can potentially reduce research costs by minimizing redundant studies, leading to significant savings for pharmaceutical companies.
Policy Influence: The research has the potential to influence national and international drug policies regarding excipients in pediatric formulations​(Research impact toolkit)​(Research Impact Knowled…).
Public Awareness and Education: The study could increase public awareness about the safety of pediatric medications and promote informed decision-making by healthcare providers​(Research Impact Knowled…).
This organized analysis reflects the diverse and extensive potential impacts of the study across multiple domains and stakeholders.